Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by Blair William & Co. IL

Blair William & Co. IL lifted its position in Doximity, Inc. (NASDAQ:DOCS) by 10.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 100,139 shares of the company’s stock after acquiring an additional 9,539 shares during the quarter. Blair William & Co. IL owned 0.05% of Doximity worth $2,801,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in DOCS. Jump Financial LLC acquired a new stake in Doximity during the fourth quarter worth about $202,000. Vanguard Personalized Indexing Management LLC acquired a new position in Doximity during the 4th quarter valued at approximately $391,000. Norges Bank bought a new position in Doximity during the 4th quarter worth $35,995,000. Edmond DE Rothschild Holding S.A. increased its position in Doximity by 15.1% in the fourth quarter. Edmond DE Rothschild Holding S.A. now owns 2,302,240 shares of the company’s stock worth $64,555,000 after buying an additional 301,290 shares during the period. Finally, Olympiad Research LP bought a new stake in Doximity in the fourth quarter valued at $222,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Stock Performance

Doximity stock opened at $40.88 on Monday. The firm has a market cap of $7.58 billion, a price-to-earnings ratio of 56.78, a price-to-earnings-growth ratio of 5.15 and a beta of 1.27. Doximity, Inc. has a 1 year low of $19.71 and a 1 year high of $41.05. The firm’s 50 day moving average price is $33.47 and its two-hundred day moving average price is $29.09.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.06. The business had revenue of $126.68 million for the quarter, compared to the consensus estimate of $119.88 million. Doximity had a net margin of 32.53% and a return on equity of 19.26%. As a group, equities analysts predict that Doximity, Inc. will post 0.8 EPS for the current fiscal year.

Insider Transactions at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,500 shares of the firm’s stock in a transaction dated Monday, July 1st. The stock was sold at an average price of $28.00, for a total transaction of $70,000.00. Following the completion of the sale, the director now directly owns 10,258 shares in the company, valued at approximately $287,224. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Watkin Phoebe L. Yang sold 1,940 shares of the business’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $28.22, for a total transaction of $54,746.80. Following the transaction, the director now directly owns 12,269 shares in the company, valued at approximately $346,231.18. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Kira Scherer Wampler sold 2,500 shares of the company’s stock in a transaction on Monday, July 1st. The stock was sold at an average price of $28.00, for a total transaction of $70,000.00. Following the completion of the transaction, the director now directly owns 10,258 shares in the company, valued at $287,224. The disclosure for this sale can be found here. Insiders sold a total of 37,951 shares of company stock valued at $1,271,018 over the last quarter. Company insiders own 39.40% of the company’s stock.

Wall Street Analyst Weigh In

DOCS has been the subject of a number of analyst reports. JPMorgan Chase & Co. boosted their target price on shares of Doximity from $27.00 to $30.00 and gave the company a “neutral” rating in a research note on Monday, August 19th. Canaccord Genuity Group raised their target price on Doximity from $37.00 to $40.00 and gave the company a “buy” rating in a research report on Tuesday, August 20th. Needham & Company LLC upgraded Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target for the company in a research report on Friday, August 9th. Robert W. Baird raised their price target on Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a report on Tuesday, September 17th. Finally, Barclays increased their target price on shares of Doximity from $31.00 to $35.00 and gave the company an “equal weight” rating in a research report on Friday, August 9th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $32.42.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.